S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)
S&P 500   4,962.34 (-0.97%)
DOW   37,949.95 (+0.46%)
QQQ   414.84 (-2.02%)
AAPL   165.11 (-1.16%)
MSFT   399.28 (-1.23%)
META   479.55 (-4.43%)
GOOGL   153.82 (-1.40%)
AMZN   174.34 (-2.72%)
TSLA   147.17 (-1.84%)
NVDA   769.00 (-9.18%)
AMD   146.41 (-5.59%)
NIO   3.81 (-4.75%)
BABA   69.03 (+0.22%)
T   16.42 (+0.55%)
F   12.11 (+0.41%)
MU   106.73 (-4.65%)
GE   148.53 (-2.88%)
CGC   7.99 (+2.04%)
DIS   112.27 (-0.14%)
AMC   3.18 (+8.90%)
PFE   25.97 (+2.28%)
PYPL   61.99 (-0.18%)
XOM   119.84 (+1.11%)

Audentes Therapeutics (BOLD) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
bbc.co.uk logoBold Girls
bbc.co.uk - April 11 at 12:28 PM
businesswire.com logoBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
businesswire.com - April 11 at 8:00 AM
morningstar.com logoBoundless Bio Inc BOLD
morningstar.com - April 11 at 7:27 AM
businesswire.com logoBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024
businesswire.com - April 8 at 8:00 AM
businesswire.com logoBoundless Bio Announces Pricing of Initial Public Offering
businesswire.com - March 27 at 6:55 PM
cnn.com logoMarriott Bonvoy Bold credit card review 2023
cnn.com - November 25 at 10:27 AM
yahoo.com logoKristen Louelle Is Bold and Beautiful in These 4 Pics in Atlantic City
yahoo.com - November 4 at 1:32 AM
usatoday.com logoWhat Top 25 upsets are coming this weekend? Bold predictions for Week 5 in college football
usatoday.com - October 27 at 6:28 PM
forbes.com logoHow Bold Leadership Can Help Or Hurt You
forbes.com - April 27 at 7:53 PM
finance.yahoo.com logoBold Therapeutics Presents Jaw-Dropping Interim Phase 2 Clinical Data for BOLD-100 in the Treatment of Advanced Colorectal Cancer at AACR 2023
finance.yahoo.com - April 23 at 9:14 AM
entrepreneur.com logoThe Benefits of Bold Leadership and How Leaders Can Develop a Bold Mindset
entrepreneur.com - April 18 at 9:14 PM
usatoday.com logoFive bold predictions for the men's NCAA Tournament's Final Four
usatoday.com - April 2 at 9:54 AM
usatoday.com logoMen's NCAA Tournament 2023: 10 bold predictions for March Madness
usatoday.com - March 26 at 7:32 AM
finance.yahoo.com logo5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
finance.yahoo.com - March 23 at 12:28 PM
forbes.com logoTikTok Has A New ‘Bold Glamour’ AI-Powered Filter, Here Are The Risks
forbes.com - March 17 at 6:49 PM
yahoo.com logoYou but better? Not so fast. Unpacking TikTok's controversial 'Bold Glamour' filter
yahoo.com - March 12 at 11:37 AM
news.yahoo.com logoOn King's holiday, daughter calls for bold action over words
news.yahoo.com - January 18 at 3:25 PM
dailymail.co.uk logoIt's blue Monday... Let's embrace it says JO ELVIN, with this season's refreshingly bold take on the colour
dailymail.co.uk - January 17 at 1:43 PM
forbes.com logoPersonal And Career Success One Bold Move A Day
forbes.com - January 13 at 1:21 PM
theguardian.com logoLeBron exits LA and an American F1 star: our bold sports predictions for 2023
theguardian.com - January 5 at 6:36 PM
usatoday.com logoBold predictions for college football's Week 11 have Alabama and LSU on upset alert
usatoday.com - November 14 at 12:48 AM
nypost.com logoLEGO makes bold claim on how bricks affect mental health
nypost.com - October 8 at 12:15 AM
investing.com logoBOLD_old Historical Data
investing.com - August 24 at 11:51 PM
yahoo.com logoFDA approves first fast-acting oral drug for clinical depression
yahoo.com - August 22 at 5:49 PM
yahoo.com logoAppnovation Earns Seven 2022 MUSE Creative Awards
yahoo.com - March 18 at 7:26 AM
finance.yahoo.com logoNemours Children's Health Officially Launches New Brand to Advance Children's Health
finance.yahoo.com - September 16 at 11:18 PM
feeds.benzinga.com logoAstellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Hold
feeds.benzinga.com - September 14 at 7:12 AM
Get Audentes Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter.

Strange new buyer driving up gold (Ad)

One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented."

But there's a much better move you can make to get in front of these big moves today.

BOLD Media Mentions By Week

BOLD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BOLD
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

BOLD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BOLD Articles
This Week

0

0

BOLD Articles
Average Week

Get Audentes Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BOLD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners